Company / Cost of Revenue
Avantor Cost of Revenue History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$4.4B
FY2025
5-year range
$4.3B / $4.9B
FY2021-FY2025
Trend
-2.0%
vs FY2024
Sector context
#20 of 113
Health Care
What the data says
Avantor's cost of revenue of $4.4B is higher than 82% of companies in the Health Care sector (FY2025). Cost of Revenue has fluctuated over the past 9 years, ranging from $815M in FY2019 to $4.9B in FY2021.
Based on SEC 10-K filings.
$4.4B in FY2025 with a 5-year CAGR of +0.5%. Top quartile in the Health Care sector.
Improved from $4.6B to $4.4B over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +0.8%
- 5-Year CAGR
- +0.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 113This company $4.4B Sector average $11.3B
▼
-60.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +0.5%, indicating consistent growth.
- In FY2025, cost of revenue decreased 2.0% year-over-year.
- Ranks #20 out of 113 companies in the Health Care sector.
- Peak cost of revenue was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.4B | -2.0% |
| FY2024 | $4.5B | -2.2% |
| FY2023 | $4.6B | +6.7% |
| FY2022 | $4.3B | -11.7% |
| FY2021 | $4.9B | +13.2% |
| FY2020 | $4.3B | +429.5% |
| FY2019 | $814.6M | -79.9% |
| FY2018 | $4.0B | +396.5% |
| FY2017 | $814.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026